ClinicalTrials.gg
RecruitingNCT07440862Updated Feb 27, 2026

Effects of Pelvic Floor Exercises and Pelvic Support Belt in Symphysis Pubis Dysfunction

An interventional study of pelvic floor excercises and pelvic support belt in Pubic Symphysis Diastasis, sponsored by Riphah International University. Recruiting at 1 site in Pakistan. Open to female participants aged 25 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-27.

Primary conditionPelvic Girdle PainRegistry: Motor ActivityReclassifiedWhy we changed it
Registry
Motor Activity — the first condition term the registry derived for this study.
ClinicalTrials.gg
Pelvic Girdle Pain
Why
  1. Motor Activity is a broad heading, used only when no more specific condition is named.
  2. The study's title name Pelvic Girdle Pain.
Confidence
High: the new condition is named in the study's own title. Of 46 hand-checked studies reclassified this way, 72% were exactly right and 89% in the right disease family; the registry's first term was right for 4% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Riphah International University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Mar 2026, 8 months ago, but the record still lists the study as recruiting.
  • Registered 8 months after the study started (first participant enrolled Jun 2025, registered Feb 2026).
  • Started Jun 2025; still recruiting 1 year 5 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
48
Allocation
Randomized
Ages
25 Years to 40 Years
Sex
Female
01

Study summary

Symphysis Pubis Dysfunction (SPD) is a medical condition that affects the pelvic region, particularly the joint that joins the two pubic bones at the front of the pelvis, the pubic symphysis. Although normally this joint is quite stable, the ligaments surrounding the pelvis loosen in preparation for childbirth due to hormonal changes during pregnancy, particularly an increase in a hormone called relaxin. This may result in pelvic joint instability, which can cause pain and discomfort, usually in the pelvic region, lower abdomen, or groin. Symptoms, physical examination, and medical history are frequently used to diagnose SPD. Medical professionals may also test for pelvic instability and assess for tenderness near the pubic symphysis. Imaging (such as an X-ray or ultrasound) may be performed to rule out other disorders in certain situations, but it is not always required.

The study will be a randomized clinical trial and will be conducted in Fatima Medical Complex, Hameeda Bashir Hospital, Sadaf Yahya Hospital and Tehsil Head Quarter (THQ) Daska. This study will be completed in time duration of 10 months after the approval of synopsis. Non-probability convenience sampling technique will be used and 48 participants will be recruited in study after randomization. The subjects will be divided into two groups. Group A will receive Phonophoresis for 10 minutes as baseline treatment and pelvic floor exercises (Kegel Exercises, Bridging, Pelvic Tilt, Squats, Dead Bug) with pelvic support belt whereas Group B will receive only pelvic floor exercises and Phonophoresis as baseline treatment. The tools that will be used are Oswestry Disability Index, Pelvic Floor Impact Questionnaire (PFIQ-7) and Visual Analog Scale (VAS) for assessing Pain, Disability and functioning. After data collection, data will be analyzed by using SPSS version 25.

Keywords: pelvic floor, exercises, post-partum, symphysis pubis dysfunction, pain, function, disability

02

Conditions studied

  • Pubic Symphysis Diastasis

Browse trials for

Keywords

  • pelvic floor
  • exercises
  • post-partum
  • symphysis pubis dysfunction
  • pain
  • function
  • disability
03

In context

Pelvic Girdle Pain Reclassified

63 studies on the registry are indexed under Pelvic Girdle Pain; 14 are open to participants now.

This study's planned enrollment of 48 is close to the median of 53 across 45 interventional studies indexed under Pelvic Girdle Pain.

Browse Pelvic Girdle Pain studies →

Lead sponsor

Riphah International University is the lead sponsor of 2,193 studies on the registry; 650 are open to participants now.

Compared within Pelvic Girdle Pain, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Motor Activity. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
25 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Multigravida females
  • Women diagnosed with pubic symphysis dysfunction
  • Females willing to provide to participate in the study.
  • Functional Status: Able to engage in physical activity without significant .
  • Symptom Severity: Experience pain and disability due to symphysis pubis dysfunction
  • Previous Treatment: May not have undergone pelvic floor therapy.

Exclusion criteria

Exclusion Criteria:

    • Participants below 8 years and above 12 years.

      • Any Psychological issue
      • Primigravida Females
      • Significant neurological disorders, pelvic pain syndromes, or conditions affecting pelvic floor function.
      • Pelvic Floor Disorders: Presence of other pelvic floor disorders (e.g., Fecal Incontinence, Urinary Incontinence)
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
48 participants (estimated)

Study arms

  • Experimental
    pelvic floor excercises

    Group A patients will be given 10 minutes session of Phonophoresis as baseline treatment and pelvic floor exercises with 10 repetitions maximun including Kegel Exercises, Dead Bug, Bridging, Pelvic tilt and Squats with 2 sets each for up to 3-5 times a week with pelvic support belt.

    Other: pelvic floor excercises · Other: pelvic support belt

  • Experimental
    pelvic support belt

    Group B patients will be given 10 minutes session of Phonophoresis as baseline treatment and pelvic floor exercises with 10 repetitions maximum including Kegel Exercises, Dead Bug, Bridging, Pelvic tilt and Squats with 2 sets each for up to 3-5 times a week without pelvic support belt

    Other: pelvic support belt

Interventions

  • Otherpelvic floor excercises

    Group A patients will be given 10 minutes session of Phonophoresis as baseline treatment and pelvic floor exercises with 10 repetitions maximun including Kegel Exercises, Dead Bug, Bridging, Pelvic tilt and Squats with 2 sets each for up to 3-5 times a week with pelvic support belt

  • Otherpelvic support belt

    Group B patients will be given 10 minutes session of Phonophoresis as baseline treatment and pelvic floor exercises with 10 repetitions maximum including Kegel Exercises, Dead Bug, Bridging, Pelvic tilt and Squats with 2 sets each for up to 3-5 times a week without pelvic support belt

06

What researchers measure

Primary outcomes

  1. Visual Analog Scale (VAS):

    Visual Analogue Scale (VAS) is frequently used to gauge the severity of pain in a variety of healthcare settings across the globe. For determining how much pain a patient is suffering, it is an easy, rapid, and efficient tool.(13) VAS exhibits great repeatability and test-retest reliability.(14) VAS features a continuous scale made up of both horizontal and vertical lines, which are referred to as the vertical VAS and horizontal visual analogue scale. The vertical and horizontal VAS have a strong association. However, the horizontal VAS score is slightly lower than the vertical VAS score

    Time frame: 6th week

  2. Oswestry Disability Index (ODI)

    The original Oswestry Disability Index (ODI) was developed in a specialist referral clinic for patients with chronic low back pain. (17) The Oswestry (version 2.1a) 21 is a 10-item, self report questionnaire that consists of items regarding the physical effects of pain and asks participants to rate their pain level (Section 1) and their ability to perform 9 tasks (Sections 2 through 10). Responses are graded on 6-point scales (0-5) for each item, with higher scores indicative of higher levels of perceived disability. The ODI refers to the ratio of the total score to the maximum score and is expressed as a percentage

    Time frame: 6th week

  3. Pelvic Floor Impact Questionnaire (PFIQ-7):

    PFIQ covers the impact of POP on daily life.(19) The PFIQ consists of 21 items that measures the impact of bladder, bowel, and vaginal symptoms on daily activity, social/relationships, and emotional health. Response options range from 0 ("not at all") to 3PFIQ covers the impact of POP on daily life.(19) The PFIQ consists of 21 items that measures the impact of bladder, bowel, and vaginal symptoms on daily activity, social/relationships, and emotional health. Response options range from 0 ("not at all") to 3 ("quite a bit"). In each scale, the mean score of answered items is multiplied by 33.3 to obtain the scale score (range 0-100). Summary scores are calculated by adding up the scale scores (range 0-300). Higher scores indicate more impact on daily activity

    Time frame: 6th week

07

Study locations

1 of 1 sites recruiting
  • Sadaf Yahya Hospital
    Daska Kalan, Pakistan
    Recruiting
    • mehar un nisa shafique, MS · Contactmeharun.nisa@riphah.edu.pk · 03344563221
    • wajeeha siddiqui, MSPT-WH · Principal investigator
08

References and documents

Publications

  • Patil VR, Sharma RK, editors. POST PREGNANCY-SYMPHYSIS PUBIS DYSFUNCTION AND PAIN MANAGEMENT USING MODIFIED PELVIC BELTS: A REVIEW. Obstetrics and Gynaecology Forum; 2024.
  • Borscheva A, Pertseva G, Alekseeva N. Dysfunction of the symphysis as one of the actual problems of modern obstetrics. Medical Herald of the South of Russia. 2021;12(3):44-9.
  • Mamipour H, Farazmehr S, Negahban H, Nazary-Moghadam S, Dehghan-Manshadi F, Navi Nezhad M, Jafari S, Sharifzadeh M. Effect of Core Stabilization Exercises on Pain, Functional Disability, and Quality of Life in Pregnant Women With Lumbar and Pelvic Girdle Pain: A Randomized Controlled Trial. J Manipulative Physiol Ther. 2023 Jan;46(1):27-36. doi: 10.1016/j.jmpt.2023.05.005. Epub 2023 Jul 7. PubMed 37422748 ↗
  • ALIAA EH, MAGDA SM, MOHAMED FA. Effect of Phonophoresis and Pelvic Brace on Symphysis Pubis Pain after Delivery. The Medical Journal of Cairo University. 2024;92(03):31-7.
  • Morimoto K, Harrington A, Nelson C, Loveless B. Osteopathic approach to sacroiliac joint pain in pregnant patients. J Osteopath Med. 2022 Feb 18;122(5):235-242. doi: 10.1515/jom-2021-0231. PubMed 35176817 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07440862
Responsible party
Sponsor
First posted
Feb 27, 2026
Start date
Jun 1, 2025
Primary completion
Mar 2026 (estimated)
Completion
Mar 1, 2026 (estimated)
Last update
Feb 27, 2026

Study contacts

imran amjad, PhD
Contact
imran.amjad@riphah.edu.pk
03324390125
mehar un nisa shafique, MS
principal investigator · Riphah International University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion